Pfizer’s Paxlovid cooperation with CSPC Pharmaceutical Group is the latest in its expansion efforts in China.
CSPC, which earlier this year won approval from Chinese regulators for the country’s first locally developed mRNA Covid vaccine, will manufacture and sell the medication in mainland China, according to a Pfizer spokesperson. That coincided with a surge in demand for antivirals after Beijing’s abrupt dismantling of most Covid restrictions in late 2022 unleashed a virus wave that infected 80% of the population in less than two months.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: staronline - 🏆 4. / 75 Read more »